ORGN vs REX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

ORGN

53.7
AI Score
VS
ORGN Wins

REX

49.7
AI Score

Investment Advisor Scores

ORGN

54score
Recommendation
HOLD

REX

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ORGN REX Winner
Forward P/E 0 12.4533 Tie
PEG Ratio 0 1.7383 Tie
Revenue Growth -91.2% 6.3% REX
Earnings Growth 266.7% 390.2% REX
Tradestie Score 53.7/100 49.7/100 ORGN
Profit Margin 0.0% 18.3% REX
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ORGN 1M: -32.1% · 3M: -58.3% REX 1M: +4.2% · 3M: -2.7%

Current Technical Phase

ORGN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -27.3%), weak momentum, RSI 34

RSI (14): 33.5 · Price: $0.95

REX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 56

RSI (14): 55.9 · Price: $43.75

Fundamentals Snapshot

Metric ORGN REX
Market Cap — —
Forward P/E -3.1 14.6
Trailing P/E — 11.7
Revenue (TTM) — —
Revenue Growth -0.9% 0.1%
Gross Margin 0.0% 0.2%
Operating Margin -34.6% 0.2%
EPS -48.43 3.72
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ORGN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.